Early effectiveness and safety analysis of belimumab in addition to standard treatment in patients with systemic lupus erythematosus
{{output}}
Objectives: This study aimed to evaluate the early effectiveness and safety of belimumab in addition to standard therapy in patients with systemic lupus erythematosus (SLE) for 24 weeks. ... ...
